Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04162002 · ClinicalTrials.gov registry record · Phase 1
Restylane® Lyft Filler Injection for Hand Rejuvenation on First Impressions
A Phase 1 study of Hand Rejuvination, sponsored by DeNova Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04162002: Completed Phase 1 study of Hand Rejuvination, sponsored by DeNova Research.
NCT04162002 is a Phase 1 study of Hand Rejuvination that has completed, run by DeNova Research. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04162002, a Phase 1 study of Hand Rejuvination, has completed, sponsored by DeNova Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to determine the effects of Restylane® Lyft Filler injection into the back of the hand on first impressions.
Primary Outcome
Subjects will have a picture of their hand evaluated by third party physicians on the basis of: Social Skills Positive mood, gets along with others well, friendly 1-10 rating Academic Performance Intelligent, highly educated, received good grades in school 1-10 rating Dating Success Dates frequently, lacks dating anxiety 1-10 rating Occupational Success Good worker, competent, motivated for success, suitable as potential employee 1-10 rating Attractiveness Pleasing appearance 1-10 rating F
Conditions Studied
Interventions
- DRUG Restylane® Lyft
Study Locations (1)
Illinois
- DeNova Research - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-10-10 |
| Est. Completion | 2019-11-18 |
| Phase | Phase 1 |
What the finished NCT04162002 record still lists
NCT04162002 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Hand Rejuvination appearing as the primary indexed condition, and to 1 intervention - of which Restylane® Lyft is the first listed.
NCT04162002 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04162002 about?
NCT04162002 is a clinical study titled "Restylane® Lyft Filler Injection for Hand Rejuvenation on First Impressions". The purpose of this research is to determine the effects of Restylane® Lyft Filler injection into the back of the hand on first impressions.
What is the current status of trial NCT04162002?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2019-10-10. Estimated completion is 2019-11-18.
What conditions does trial NCT04162002 study?
This clinical trial studies the following conditions: Hand Rejuvination.
What interventions are being tested in trial NCT04162002?
The interventions under investigation include: Restylane® Lyft (DRUG).
Who is sponsoring clinical trial NCT04162002?
This trial is sponsored by DeNova Research, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04162002 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04162002's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI